The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A survey: Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias

The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A survey

Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias

Authors

  • Vincenzo De Sanctis Quisisana Hospital, Ferrara
  • Ashraf Soliman Department of Pediatrics, Division of Endocrinology, Hamad General Hospital, Doha, Qatar and Department of Pediatrics, Division of Endocrinology, Alexandria University Children’s Hospital, Alexandria, Egypt
  • Ploutarchos Tzoulis Department of Diabetes and Endocrinology, Whittington Hospital, University College London, London, UK
  • Shahina Daar Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman
  • Antonis Kattamis Thalassemia Unit, Division of Pediatric Hematology-Oncology, First Department of Pediatrics, University of Athens, "Agia Sofia" Children's Hospital, Athens, Greece
  • Polyxeni Delaporta Thalassemia Unit, Division of Pediatric Hematology-Oncology, First Department of Pediatrics, University of Athens, "Agia Sofia" Children's Hospital, Athens, Greece
  • Mohamed A. Yassin National Center for Cancer Care and Research, Medical Oncology Hematology Section HMC, Doha, Qatar
  • Mehran Karimi Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Duran Canatan Medical Director of Antalya Genetic Diseases Center, Antalya, Turkey
  • Soad Al Jaouni Head Division of Pediatric Hematology Oncology, Department of Hematology Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
  • Maria Concetta Galati Department of Pediatric Haematoncology, Thalassaemia and Prenatal Diagnosis Regional Center, Pugliese-Ciaccio Hospital, Catanzaro, Italy
  • Giuseppe Raiola Department of Paediatrics, Pugliese-Ciaccio Hospital,Catanzaro, Italy
  • Giuseppe Messina UOSD Microcitemie, Grande Ospedale Metropolitano “Bianchi- Melacrino- Morelli”, Reggio Calabria, Italy
  • Saveria Campisi UOSD Thalassemia, Umberto I° Hospital, Siracusa, Italy
  • Forough Saki Shiraz Endocrinology and Metabolism Research Center, Shiraz, Iran
  • Dulani Kottahachchi Thalassaemia Care Unit, Colombo North Teaching Hospital, Sri Lanka
  • Valeria Kaleva Varna Expert Center for Coagulopathies and Rare Anemias, Sofia, Bulgaria
  • Kristina Petrova Varna Expert Center for Coagulopathies and Rare Anemias, Sofia, Bulgaria
  • Atanas Banchev Pediatric Hematology-Oncology, University Hospital "Tzaritza Giovanna - ISUL", Sofia, Bulgaria
  • Christos Kattamis First Department of Paediatrics, National Kapodistrian University of Athens, Greece

Keywords:

Thalassemias, prevalence, glucose dysregulations

Abstract

.

References

De Sanctis V, Soliman A,Tzoulis P, et al. Early detection of glucose dysregulation (GD) in patients with β-thalassemia major: Review of current diagnostic criteria and the ICET-A survey. Curr Trends Endocrinol. 2021;11:1-11.

He LN, Chen W, Yang Y, et al. Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis. Biomed Res Int 2019;2019:6573497.

Farmaki K, Angelopoulos N, Anagnostopoulos G, et al. Effect of enhanced iron chelation therapy on glucose metabolism in patients with b-thalassaemia major. Br J Hematol. 2006;134:438-444.

Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A. Guidelines for diagnosis and management of Beta-thalassemia intermedia. Pediatr Hematol Oncol. 2014;31:583-96.

De Sanctis V, Soliman AT. ICET-A an Opportunity for Improving Thalassemia Management. J Blood Disord. 2014;1: 1-2.

Chuncharunee S, Teawtrakul N, Siritanaratkul N, Chueamuangphan N. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand. PLoS One 2019;14:e0214148.

Downloads

Published

01-07-2021

Issue

Section

LETTERS TO EDITOR

How to Cite

1.
De Sanctis V, Soliman A, Tzoulis P, Daar S, Kattamis A, Delaporta P, et al. The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A survey: Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias . Acta Biomed [Internet]. 2021 Jul. 1 [cited 2024 Jul. 22];92(3):e2021240. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11733